These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29309927)

  • 41. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
    Chen EY; Mazure NM; Cooper JA; Giaccia AJ
    Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activator or inhibitor? GSK-3 as a new drug target.
    Takahashi-Yanaga F
    Biochem Pharmacol; 2013 Jul; 86(2):191-9. PubMed ID: 23643839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis.
    Saiprasad G; Chitra P; Manikandan R; Sudhandiran G
    Eur J Cancer; 2014 Sep; 50(14):2489-507. PubMed ID: 25047426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of paclitaxel-induced breast cancer cell death via the glycogen synthase kinase-3β-mediated B-cell lymphoma 2 regulation.
    Noh KT; Cha GS; Kang TH; Cho J; Jung ID; Kim KY; Ahn SC; You JC; Park YM
    BMB Rep; 2016 Jan; 49(1):51-6. PubMed ID: 26246283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
    Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
    Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.
    MacAulay K; Doble BW; Patel S; Hansotia T; Sinclair EM; Drucker DJ; Nagy A; Woodgett JR
    Cell Metab; 2007 Oct; 6(4):329-37. PubMed ID: 17908561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.
    Mancinelli R; Carpino G; Petrungaro S; Mammola CL; Tomaipitinca L; Filippini A; Facchiano A; Ziparo E; Giampietri C
    Oxid Med Cell Longev; 2017; 2017():4629495. PubMed ID: 29379583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.
    Manoukian AS; Woodgett JR
    Adv Cancer Res; 2002; 84():203-29. PubMed ID: 11883528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
    Olianas MC; Dedoni S; Onali P
    Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
    McCubrey JA; Steelman LS; Bertrand FE; Davis NM; Abrams SL; Montalto G; D'Assoro AB; Libra M; Nicoletti F; Maestro R; Basecke J; Cocco L; Cervello M; Martelli AM
    Leukemia; 2014 Jan; 28(1):15-33. PubMed ID: 23778311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer.
    Ding L; Billadeau DD
    Expert Opin Ther Targets; 2020 May; 24(5):417-426. PubMed ID: 32178549
    [No Abstract]   [Full Text] [Related]  

  • 55. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GSK-3: tricks of the trade for a multi-tasking kinase.
    Doble BW; Woodgett JR
    J Cell Sci; 2003 Apr; 116(Pt 7):1175-86. PubMed ID: 12615961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.
    Tseng PC; Chen CL; Shan YS; Lin CF
    Oncotarget; 2016 Mar; 7(12):15150-60. PubMed ID: 26934444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.
    Cross DA; Culbert AA; Chalmers KA; Facci L; Skaper SD; Reith AD
    J Neurochem; 2001 Apr; 77(1):94-102. PubMed ID: 11279265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.